Marcin S, Lene T, Richard JW, Marina B, Peter VB, George AWB, Emilio F, Frederique G, Annamaria I, Peter M, Ingrid M, Esperanza N, Wolfgang ASandMaria, Antonietta D
The medications work
Ala/Lys ratio has been used as a marker for mitochondrial metabolism 41
Journal of Autism and Developmental Disorders, 42 (9), 19281938
When initial therapy proves insufficient, treatment escalation includes: Biologic DMARDs targeting specific inflammatory pathways (TNF inhibitors, IL-6 inhibitors, T-cell costimulation blockers, B-cell depleting agents) Targeted synthetic DMARDs such as JAK inhibitors (tofacitinib, baricitinib, upadacitinib), which carry FDA boxed warnings for serious cardiovascular events, malignancy, and thrombosis [24] [25] Combination DMARD therapy Short-term glucocorticoids for symptom control during treatment initiation Before starting biologic or targeted synthetic DMARDs, screening for tuberculosis and hepatitis B is recommended, along with appropriate vaccinations according to ACR guidelines
